Literature DB >> 9247093

Cloning of the gp63 surface protease of Leishmania infantum. Differential post-translational modifications correlated with different infective forms.

G González-Aseguinolaza1, F Almazán, J F Rodríguez, A Marquet, V Larraga.   

Abstract

The Leishmania cell surface virulence factor gp63 is a protease family that plays an important role in the survival of the parasite protozoon into the host macrophages. We have cloned and characterised the gp63 gene from L. infantum. The sequence analysis of the gene indicates the existence of a high degree of conservation with the other old world species L. major and L. donovani. The similarity is lower with new world species with the exception of L. chagasi which shows a strikingly high percentage of identity (99-100%). In L. infantum the gp63 gene expresses two polypeptides of 58 and 60 kDa, respectively, which show a similar proteolytic activity. The 60 kDa polypeptide is expressed during the whole life cycle of the promastigote form of the parasite with a moderate increase at the stationary phase of growth while the 58 kDa product, although slightly present in the logarithmic phase, notable increases its expression during the highly infectious stationary phase. RNA analysis showed that the presence in L. chagasi of these two polypeptides correlates with two RNA molecules and with the degree of parasite infectivity, whereas in the case of L. infantum a single 3 kb messenger RNA is detected through the whole promastigote life cycle. Our data indicate that in L. infantum, the differences in gene expression of the gp63 protease family according to parasite phase of growth seem to be due to a differential pattern of glycosilation of the polypeptides which correlates with the different infective forms of the promastigote form of the parasite.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9247093

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  4 in total

1.  Nuclear DNA polymerase beta from Leishmania infantum. Cloning, molecular analysis and developmental regulation.

Authors:  S Taladriz; T Hanke; M J Ramiro; M García-Díaz; M García De Lacoba; L Blanco; V Larraga
Journal:  Nucleic Acids Res       Date:  2001-09-15       Impact factor: 16.971

2.  Cloning, functional analysis and post-transcriptional regulation of a type II DNA topoisomerase from Leishmania infantum. A new potential target for anti-parasite drugs.

Authors:  Tobias Hanke; María J Ramiro; Sonia Trigueros; Joaquim Roca; Vicente Larraga
Journal:  Nucleic Acids Res       Date:  2003-08-15       Impact factor: 16.971

3.  Tyrosine aminotransferase from Leishmania infantum: A new drug target candidate.

Authors:  Miguel Angel Moreno; Ana Alonso; Pedro Jose Alcolea; Ariel Abramov; Mario García de Lacoba; Jan Abendroth; Sunny Zhang; Thomas Edwards; Don Lorimer; Peter John Myler; Vicente Larraga
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2014-07-30       Impact factor: 4.077

4.  Leishmania infantum UBC1 in Metacyclic Promastigotes from Phlebotomus perniciosus, a Vaccine Candidate for Zoonotic Visceral Leishmaniasis.

Authors:  Jaime Larraga; Pedro J Alcolea; Ana M Alonso; Luis T C Martins; Inmaculada Moreno; Mercedes Domínguez; Vicente Larraga
Journal:  Vaccines (Basel)       Date:  2022-02-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.